Acromegaly Clinical Trials

25 recruiting

Acromegaly Trials at a Glance

16 actively recruiting trials for acromegaly are listed on ClinicalTrialsFinder across 6 cities in 27 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Milan, Los Angeles, and Cluj-Napoca. Lead sponsors running acromegaly studies include IRCCS San Raffaele, Barts & The London NHS Trust, and Ascil Australia Pty LTD.

Browse acromegaly trials by phase

Treatments under study

About Acromegaly Clinical Trials

Looking for clinical trials for Acromegaly? There are currently 25 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Acromegaly trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Acromegaly clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

ProlactinomaCushing DiseasePanhypopituitarism+1 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2,000 enrolled1 locationNCT00001595
Recruiting
Phase 3

A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs

Acromegaly
Debiopharm International SA119 enrolled71 locationsNCT06930625
Recruiting
Phase 2

ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly

Acromegaly
Alexion Pharmaceuticals, Inc.60 enrolled45 locationsNCT07037420
Recruiting
Phase 1

Study of MAR002 in Healthy Men

Acromegaly
Marea Therapeutics45 enrolled1 locationNCT07195175
Recruiting

Effects of Pasireotide Lar Therapy on Bone Metabolism

Acromegaly Due to Pituitary AdenomaAcromegaly
Fondazione Policlinico Universitario Agostino Gemelli IRCCS120 enrolled1 locationNCT07179926
Recruiting

Effects of Therapies in the Acromegaly Disease: Acral Morpho-functional Study

Acromegaly
Istituto Auxologico Italiano30 enrolled1 locationNCT05964712
Recruiting

Korean Regulatory Post Marketing Surveillance for Somavert

Acromegaly
Pfizer100 enrolled1 locationNCT05131100
Recruiting

Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA

Familial Isolated Pituitary AdenomaAcromegalyGigantism+3 more
Barts & The London NHS Trust10,000 enrolled3 locationsNCT00461188
Recruiting
Not Applicable

KETOgenic Diet Therapy in Patients With ACROmegaly

Acromegaly Due to Pituitary AdenomaKetogenic DietMediterranean Diet
Erasmus Medical Center60 enrolled1 locationNCT06949891
Recruiting

The RApid Switch From 1st Generation Somatostatin Analogues to PaSireOtiDe In Acromegaly

Acromegaly
IRCCS San Raffaele100 enrolled1 locationNCT06597383
Recruiting

Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess.

Acromegaly
IRCCS San Raffaele100 enrolled1 locationNCT06344650
Recruiting
Not Applicable

Diet in the Management of Acromegaly

Acromegaly
Cedars-Sinai Medical Center9 enrolled1 locationNCT05401084
Recruiting

The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research

Acromegaly
Ginkgo Leaf Center for Rare Disorders1,965 enrolled1 locationNCT03158090
Recruiting
Phase 1

A First-in-Human Study of a Controlled Release Formulation of Lanreotide acetate in healthy male volunteers

AcromegalyNeuroendocrine Tumours
Ascil Australia Pty LTD16 enrolled1 locationACTRN12620001261909
Recruiting

Developing a Simple Recognition System of Acromegaly

Acromegaly
National Taiwan University Hospital80 enrolled1 locationNCT03042026
Recruiting

Protein turnover and energy expenditure in normal subjects, growth hormone deficiency, acromegaly and Cushing's syndrome

AcromegalyNormal subjectsGH deficiency
St Vincent's Hospital80 enrolled1 locationACTRN12605000445673